Skip to main content
FATE logo

FATE · Fate Therapeutics Inc · Documents

Track FATE — free
$2.13 +0.04 (+1.91%)
Market Cap
$250.42M
Shares
119.82M
Volume · Oct 23 1.11M Avg daily vol (3M) 1.59M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type AI summary Filing Date Period Open
Showing 51–100 of 118 filings
Key facts CIK 1434316 CUSIP 31189P102 13F (30d) 15 filings 15 filers Visit website Investor relations